EGPA - Eosinophilic Granulomatosis With Polyangiitis, HES - Hypereosinophilic Syndrome
Conditions
Brief summary
The purpose of this study is to collect clinical, laboratory, and instrumental data from patients with eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome, which will then be analyzed using artificial intelligence techniques with the aim of identifying characteristics that differentiate the two diseases and can predict the response to the treatment plan.
Interventions
Blood draw for the laboratory assessment
Sponsors
Fondazione IRCCS Policlinico San Matteo di Pavia
Study design
Allocation
NA
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. 18 years of age or over 2. A diagnosis of EGPA or HES 3. Willing and able to give informed written consent, or willing to give permission for a nominated friend or relative to provide written informed assent if they are unable to do so because of physical disabilities
Exclusion criteria
1. Lack of a confirmed diagnosis of EGPA or HES. 2. Other causes of eosinophilia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| characteristics that are different between HES and EGPA | 18months |
Countries
Italy
Contacts
Primary ContactCarlomaurizio Montecucco
Backup ContactAlessandra Milanesi
Outcome results
None listed